Pilar Paredes1,2, Sergi Vidal-Sicart3,4, Francisco Campos5,4, Andrés Tapias3, Nuria Sánchez3, Sergio Martínez4,6, Lorena Carballo5, Jaume Pahisa4,6, Aureli Torné4,6, Jaume Ordi4,7,8, Francesc Carmona4,6, Francisco Lomeña3,4. 1. Nuclear Medicine Department, Hospital Clínic, Villarroel, 170 08036, Barcelona, Spain. pparedes@clinic.ub.es. 2. Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. pparedes@clinic.ub.es. 3. Nuclear Medicine Department, Hospital Clínic, Villarroel, 170 08036, Barcelona, Spain. 4. Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. 5. Nuclear Medicine Department, Radiopharmacy Unit, Hospital Clínic, Barcelona, Spain. 6. Obstetrics and Neonatology, Hospital Clinic, Institut Clínic of Gynecology, Barcelona, Spain. 7. Department of Pathology, Hospital Clínic, Barcelona, Spain. 8. Centre de Recerca en Salut Internacional de Barcelona (CRESIB), Barcelona, Spain.
Abstract
PURPOSE: Sentinel lymph node biopsy (SLNB) can be used for nodal staging in early cervical cancer. For this purpose, the tracers most commonly used are radiotracers based on technetium. For the last decade, indocyanine green (ICG) has been used as a tracer for SLNB in other malignancies with excellent results and, more recently, a combination of ICG and a radiotracer has been shown to have the advantages of both tracers. The aim of this study was to evaluate the role of ICG-99mTc-nanocolloid in SLN detection in patients with cervical cancer. METHODS: This prospective study included 16 patients with cervical cancer. The hybrid tracer was injected the day (19-21 h) before surgery for planar and SPECT/CT lymphoscintigraphy. Blue dye was administered periorificially in 14 patients. SLNs were removed according to their distribution on lymphoscintigraphy and when radioactive, fluorescent and/or stained with blue dye. Nodal specimens were pathologically analysed for metastases including by immunochemistry. RESULTS: Lymphoscintigraphy and SPECT/CT showed drainage in all patients. A total of 69 SLNs were removed, of which 66 were detected by their radioactivity signal and 67 by their fluorescence signal. Blue dye identified only 35 SLNs in 12 of the 14 patients (85.7%). All patients showed bilateral pelvic drainage. Micrometastases were diagnosed in two patients, and were the only lymphatic nodes involved. CONCLUSIONS: SLNB with ICG-99mTc-nanocolloid is feasible and safe in patients with early cervical cancer. This hybrid tracer provided bilateral SLN detection in all patients and a higher detection rate than blue dye, so it could become an alternative to the combined technique.
PURPOSE: Sentinel lymph node biopsy (SLNB) can be used for nodal staging in early cervical cancer. For this purpose, the tracers most commonly used are radiotracers based on technetium. For the last decade, indocyanine green (ICG) has been used as a tracer for SLNB in other malignancies with excellent results and, more recently, a combination of ICG and a radiotracer has been shown to have the advantages of both tracers. The aim of this study was to evaluate the role of ICG-99mTc-nanocolloid in SLN detection in patients with cervical cancer. METHODS: This prospective study included 16 patients with cervical cancer. The hybrid tracer was injected the day (19-21 h) before surgery for planar and SPECT/CT lymphoscintigraphy. Blue dye was administered periorificially in 14 patients. SLNs were removed according to their distribution on lymphoscintigraphy and when radioactive, fluorescent and/or stained with blue dye. Nodal specimens were pathologically analysed for metastases including by immunochemistry. RESULTS: Lymphoscintigraphy and SPECT/CT showed drainage in all patients. A total of 69 SLNs were removed, of which 66 were detected by their radioactivity signal and 67 by their fluorescence signal. Blue dye identified only 35 SLNs in 12 of the 14 patients (85.7%). All patients showed bilateral pelvic drainage. Micrometastases were diagnosed in two patients, and were the only lymphatic nodes involved. CONCLUSIONS: SLNB with ICG-99mTc-nanocolloid is feasible and safe in patients with early cervical cancer. This hybrid tracer provided bilateral SLN detection in all patients and a higher detection rate than blue dye, so it could become an alternative to the combined technique.
Authors: Ilary Ruscito; Maria Luisa Gasparri; Elena Ioana Braicu; Filippo Bellati; Luigi Raio; Jalid Sehouli; Michael D Mueller; Pierluigi Benedetti Panici; Andrea Papadia Journal: Ann Surg Oncol Date: 2016-05-09 Impact factor: 5.344
Authors: B E Schaafsma; F P R Verbeek; A A W Peters; J R van der Vorst; C D de Kroon; M I E van Poelgeest; J B M Z Trimbos; C J H van de Velde; J V Frangioni; A L Vahrmeijer; K N Gaarenstroom Journal: BJOG Date: 2013-02-19 Impact factor: 6.531
Authors: Henk G van der Poel; Tessa Buckle; Oscar R Brouwer; Renato A Valdés Olmos; Fijs W B van Leeuwen Journal: Eur Urol Date: 2011-04-01 Impact factor: 20.096
Authors: Stephan Jeschke; Avi Beri; Martin Grüll; Josef Ziegerhofer; Peter Prammer; Karl Leeb; Wolfgang Sega; Guenter Janetschek Journal: Eur Urol Date: 2007-03-28 Impact factor: 20.096
Authors: Gijs H KleinJan; Anton Bunschoten; Nynke S van den Berg; Renato A Valdès Olmos; W Martin C Klop; Simon Horenblas; Henk G van der Poel; Hans-Jürgen Wester; Fijs W B van Leeuwen Journal: Eur J Nucl Med Mol Imaging Date: 2016-03-28 Impact factor: 9.236
Authors: Ilse G T Baeten; Jacob P Hoogendam; Arthur J A T Braat; Ronald P Zweemer; Cornelis G Gerestein Journal: EJNMMI Res Date: 2022-06-20 Impact factor: 3.434
Authors: Philippa Meershoek; Matthias N van Oosterom; Hervé Simon; Laurent Mengus; Tobias Maurer; Pim J van Leeuwen; Esther M K Wit; Henk G van der Poel; Fijs W B van Leeuwen Journal: Eur J Nucl Med Mol Imaging Date: 2018-07-27 Impact factor: 9.236
Authors: Labrinus van Manen; Henricus J M Handgraaf; Michele Diana; Jouke Dijkstra; Takeaki Ishizawa; Alexander L Vahrmeijer; Jan Sven David Mieog Journal: J Surg Oncol Date: 2018-06-24 Impact factor: 3.454